These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4064557)

  • 61. Dietary impact on biliary lipids and gallstones.
    Hayes KC; Livingston A; Trautwein EA
    Annu Rev Nutr; 1992; 12():299-326. PubMed ID: 1503808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
    Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
    N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.
    Chijiwa K; Hirota I; Noshiro H
    Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle.
    Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Erfling W; Braverman DZ; Szczepanik-van Leeuwen P; Klein PD
    J Clin Invest; 1981 Nov; 68(5):1229-42. PubMed ID: 7298849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation.
    Tran KQ; Graewin SJ; Swartz-Basile DA; Nakeeb A; Svatek CL; Pitt HA
    Surgery; 2003 Aug; 134(2):372-7. PubMed ID: 12947343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum and bile lipids in young women with radiolucent gallstones.
    Cavallini A; Messa C; Mangini V; Argese V; Misciagna G; Giorgio I
    Am J Gastroenterol; 1987 Dec; 82(12):1279-82. PubMed ID: 3687905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pathophysiology of gallstone disease. Secretion of biliary lipids and cholesterol gallstones (author's transl)].
    Gérolami A; Montet JC
    Biol Gastroenterol (Paris); 1973; 6(1):63-71. PubMed ID: 4755783
    [No Abstract]   [Full Text] [Related]  

  • 70. Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism.
    James O; Cullen J; Bouchier IA
    Q J Med; 1975 Apr; 44(174):349-67. PubMed ID: 1178813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of cicloxilic acid on bile lipid composition in patients with gallstones: a multicenter trial.
    Carulli N; Ponz de Leon M; Podda M; Di Padova C; Zuin M
    Digestion; 1983; 28(2):102-7. PubMed ID: 6360773
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
    Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
    Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans.
    Hillebrant CG; Nyberg B; Einarsson K; Eriksson M
    Gut; 1997 Nov; 41(5):700-4. PubMed ID: 9414982
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.
    Barbara L; Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R
    Digestion; 1976; 14(3):209-19. PubMed ID: 955328
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bile and plasma lipid composition in non-obese normolipidemic subjects with and without cholesterol gallstones.
    Halpern Z; Rubin M; Harach G; Grotto I; Moser A; Dvir A; Lichtenberg D; Gilat T
    Liver; 1993 Oct; 13(5):246-52. PubMed ID: 8259036
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of ursodeoxycholic acid on biliary lipids.
    Roda E; Cipolla A; Salzetta A; Marchetto S; Pezzoli A; Accogli E; Novelli V; Polimeni C; Cerrè C; Mazzella G
    Scand J Gastroenterol Suppl; 1994; 204():16-8. PubMed ID: 7824872
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy.
    Almond HR; Vlahcevic ZR; Bell CC; Gregory DH; Swell L
    N Engl J Med; 1973 Dec; 289(23):1213-6. PubMed ID: 4748594
    [No Abstract]   [Full Text] [Related]  

  • 79. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.